在VLBW新生儿中早期口服胆乳的短期结果:一项开放式随机对照试验
Sedigheh Tehranchi1, Farzaneh Palizban1, Maryam Khoshnood Shariati1
1Clinical Research Development Center, Mahdiyeh Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Medical journal of the Islamic Republic of Iran
|March 4, 2024
概括
在非常低出生体重 (VLBW) 的新生儿中,早期口服胆汁原料 (OCP) 被发现是安全的,但没有改善短期结果. 这项研究表明,OCP不会显著影响VLBW婴儿的感染率,养里程碑或整体死亡率.
科学领域:
- 新生儿医学 新生儿医学
- 儿童营养学 儿童营养学
- 临床试验 临床试验
背景情况:
- 口腔大原培养 (OCP) 是针对非常低出生体重 (VLBW) 的新生儿提出的一项营养干预措施.
- 正在探索通过口服途径早期给予乳酪蛋白,以寻找这种脆弱人群的潜在益处.
研究的目的:
- 为了评估与VLBW新生儿早期口服乳酪相关的短期临床结果.
- 为了确定OCP是否影响关键的新生儿发病率和生长参数.
主要方法:
- 一个开放的随机对照试验,涉及VLBW新生儿.
- 参与者被随机分配,接受口服胆乳粉 (干预) 或没有口服胆乳粉 (控制).
- 统计分析包括t测试,奇方位和费舍尔精确测试,以比较群体之间的结果.
主要成果:
- 在OCP组和对照组之间没有观察到关于PICC感染,败血症,NEC,IVH,ROP或BPD的显著差异.
- 达到120cc/kg料的时间,恢复出生体重的时间,住院时间和死亡率在两组之间没有显著差异.
- 总共有76名VLBW新生儿 (37名干预,39名控制) 被纳入最终分析.
结论:
- 早期口服胆乳给药对VLBW新生儿是安全的.
- 在VLBW婴儿的评估短期结果中,OCP没有显著改善.
- 可能需要进一步的研究来探索潜在的长期影响或替代OCP协议.
更多相关视频
07:11Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
9.0K
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
2.3K
相关概念视频
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
